Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 Return-on-Tangible-Equity is 25.46% as of Mar. 2026, which is 71% below its 10-year median of 86.82. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 65.52% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Gaudium IVF And Women Health's annualized net income for the quarter that ended in Mar. 2026 was ₹334.3 Mil. Gaudium IVF And Women Health's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹1,313.1 Mil. Therefore, Gaudium IVF And Women Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 25.46%.
The historical rank and industry rank for Gaudium IVF And Women Health's Return-on-Tangible-Equity or its related term are showing as below:
NSE:GAUDIUMIVF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 18.24 Med: 86.82 Max: 140.3
Current: 18.24
During the past 5 years, Gaudium IVF And Women Health's highest Return-on-Tangible-Equity was 140.30%. The lowest was 18.24%. And the median was 86.82%.
NSE:GAUDIUMIVF's Return-on-Tangible-Equity is ranked better than 65.52% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs NSE:GAUDIUMIVF: 18.24
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Gaudium IVF And Women Health Return-on-Tangible-Equity Related Terms
Gaudium IVF And Women Health Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaudium IVF And Women Health Return-on-Tangible-Equity Chart
NSE:GAUDIUMIVF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 25.46% mean?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a Return-on-Tangible-Equity of 25.46% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Gaudium IVF And Women Health and its competitors. This is 71% below median its historical median of 86.82. Over the past decade, Gaudium IVF And Women Health's Return-on-Tangible-Equity has ranged from 18.24 to 140.30. According to the industry distribution chart, Gaudium IVF And Women Health ranks #200 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 34.5%.
Is Gaudium IVF And Women Health's Return-on-Tangible-Equity too high?
Gaudium IVF And Women Health's current Return-on-Tangible-Equity of 25.46% is 71% below median its 10-year median of 86.82. Over the past 10 years, this metric has ranged from a low of 18.24 to a high of 140.30. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. Gaudium IVF And Women Health's value of 25.46% is 152.5% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #200 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #200 out of 580 companies for Return-on-Tangible-Equity. This puts Gaudium IVF And Women Health in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.09. Gaudium IVF And Women Health's value of 25.46% is 152.5% above this benchmark. Historically, Gaudium IVF And Women Health's own Return-on-Tangible-Equity has ranged from 18.24 to 140.30 over the past decade. While the company's 10-year median is 86.82 vs. the industry median of 10.09, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current Return-on-Tangible-Equity of 25.46% is 152.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current Return-on-Tangible-Equity is 25.46%, which is 71% below median its own 10-year median of 86.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current Return-on-Tangible-Equity of 25.46%. The current Return-on-Tangible-Equity is 25.46%, which is 71% below median its 10-year median of 86.82 and 152.5% above the Healthcare Providers & Services industry median of 10.09. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current Return-on-Tangible-Equity is 25.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
